Ozempic is a drug that has received approval from the Food and Drug Administration (FDA) to lower blood sugar levels in adults suffering from type 2 diabetes.

Recently, it has gained popularity as a weight loss supplement.

Wegovy, another FDA-approved medication, is primarily prescribed for chronic weight management in adults who are obese.

Ozempic and Mounjaro both use the active ingredient semaglutide.

There are concerns that these medications, or their compounded variations, may be associated with severe gastroparesis, also known as “stomach paralysis”.

Other potential health concerns linked to these drugs include gallbladder disease and cyclic vomiting syndrome, among other serious medical conditions.

Lawsuits are being filed against the manufacturers of diabetes drugs such as Ozempic and Mounjaro.

The focus of these potential lawsuits is on the patients who have used these drugs and subsequently developed serious injuries, including stomach paralysis.

If you or someone you know has used Ozempic or Wegovy for the purpose of weight loss and later developed gastroparesis (stomach paralysis) or related stomach complications, you may be eligible to file a claim under the Ozempic Lawsuit.

Contact Keith Law Group for a free consultation.

An instant case evaluation can also be accessed via the chatbot on the webpage.

https://keithlawgroup.com/ozempic-lawsuit/